Citation: A. Somoskovi et al., The molecular basis of resistance to isoniazid, rifampin, and pyrazinamidein Mycobacterium tuberculosis, RESPIR RES, 2(3), 2001, pp. 164-168
Authors:
Bartfai, Z
Somoskovi, A
Kodmon, C
Szabo, N
Puskas, E
Kosztolanyi, L
Farago, E
Mester, J
Parsons, LM
Salfinger, M
Citation: Z. Bartfai et al., Molecular characterization of rifampin-resistant isolates of Mycobacteriumtuberculosis from Hungary by DNA sequencing and the line probe assay, J CLIN MICR, 39(10), 2001, pp. 3736-3739
Authors:
Kiehlbauch, JA
Hannett, GE
Salfinger, M
Archinal, W
Monserrat, C
Carlyn, C
Citation: Ja. Kiehlbauch et al., Use of the National Committee for Clinical Laboratory Standards guidelinesfor disk diffusion susceptibility testing in New York State laboratories, J CLIN MICR, 38(9), 2000, pp. 3341-3348
Authors:
Somoskovi, A
Hotaling, JE
Fitzgerald, M
Jonas, V
Stasik, D
Parsons, LM
Salfinger, M
Citation: A. Somoskovi et al., False-positive results for Mycobacterium celatum with the AccuProbe Mycobacterium tuberculosis complex assay, J CLIN MICR, 38(7), 2000, pp. 2743-2745
Authors:
Pfyffer, GE
Bonato, DA
Ebrahimzadeh, A
Gross, W
Hotaling, J
Kornblum, J
Laszlo, A
Roberts, G
Salfinger, M
Wittwer, F
Siddiqi, S
Citation: Ge. Pfyffer et al., Multicenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugsby using the radiometric BACTEC 460 technique and the proportion method with solid media, J CLIN MICR, 37(10), 1999, pp. 3179-3186